The company plans to raise NIS 43-52 million at a company value of NIS 126-152 million.
Biopharmaceutical company Procognia Ltd. has filed a prospectus for an IPO on the Tel Aviv Stock Exchange (TASE) to be held on March 6. The company plans to issue 7.2 million shares at a price range of NIS 6-7.20, to raise NIS 43-52 million at a company value of NIS 126-152 million before money and NIS 169-204 million after money.
Investors will also receive an option for each share purchased exercisable at NIS 7.80 per share. Investment institutions will undertake to buy 80% of the offering.
Published by Globes [online], Israel business news - www.globes.co.il - on February 27, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007